Sign inJoin waitlistJoin the waitlist

Melissa Lah

Residency Director/GME · Indiana University School of Medicine

Credentials: · · · ·

History

Residency /GME Residency · Indiana University School of Medicine
Present
Medical Genetics Residency · Indiana University School of Medicine
Present
Indiana University School of Medicine
Present

Pediatrics
Indiana University School of Medicine
2007–2010
Indiana University School of Medicine
2003–2007
University of Notre Dame
1999–2003

Research

Effects of oral sepiapterin on blood Phe concentration in a broad range of patients with phenylketonuria (APHENITY): results of an international, phase 3, randomised, double-blind,…
The Lancet · 2024 · 41 citations
Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial
The Journal of Clinical Endocrinology & Metabolism · 2023 · 36 citations
Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label study
Obesity · 2024 · 20 citations

Erika Vucko
5 papers
Stephanie Sacharow
5 papers
David Weaver
4 papers
JT
Janet Thomas
4 papers
Nicola Longo
4 papers
AB
Anish Bhatnagar
3 papers · 3 as a fellow
AS
Ashley Shoemaker
3 papers
Benjamin Helm
3 papers
David Stevenson
3 papers
EL
Elizabeth Littlejohn
3 papers
Eric Felner
3 papers
Hans Andersson
3 papers

Clinical trials

A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
Site PI · Recruiting · Phase 3
PTC Therapeutics
2024–2031
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Site PI · Recruiting · Phase 2
Pharming Technologies B.V.
2022–2027
An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics
Site PI · Recruiting
RECORDATI GROUP
2022–2032